| BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation A Bononi, C Giorgi, S Patergnani, D Larson, K Verbruggen, M Tanji, ... Nature 546 (7659), 549-553, 2017 | 387 | 2017 |
| BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs M Carbone, LK Ferris, F Baumann, A Napolitano, CA Lum, EG Flores, ... Journal of translational medicine 10, 1-7, 2012 | 382 | 2012 |
| Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival F Baumann, E Flores, A Napolitano, S Kanodia, E Taioli, H Pass, H Yang, ... Carcinogenesis 36 (1), 76-81, 2015 | 267 | 2015 |
| Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples M Russano, A Napolitano, G Ribelli, M Iuliani, S Simonetti, F Citarella, ... Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020 | 226 | 2020 |
| Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, EG Flores, ... Oncogene 35 (15), 1996-2002, 2016 | 171 | 2016 |
| High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Y Yoshikawa, M Emi, Hashimoto-Tamaoki T, M Ohmuraya, A Sato, ... Proc Natl Acad Sci U S A, 2016 | 152 | 2016 |
| A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations S Pastorino, Y Yoshikawa, HI Pass, M Emi, M Nasu, I Pagano, Y Takinishi, ... Journal of Clinical Oncology 36 (35), 3485-3494, 2018 | 137 | 2018 |
| HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients A Napolitano, DJ Antoine, L Pellegrini, F Baumann, I Pagano, S Pastorino, ... Clinical Cancer Research 22 (12), 3087-3096, 2016 | 134 | 2016 |
| Germline BAP1 mutations induce a Warburg effect A Bononi, H Yang, C Giorgi, S Patergnani, L Pellegrini, M Su, G Xie, ... Cell Death & Differentiation 24 (10), 1694-1704, 2017 | 131 | 2017 |
| Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling F Qi, G Okimoto, S Jube, A Napolitano, HI Pass, R Laczko, RM DeMay, ... The American journal of pathology 183 (5), 1654-1666, 2013 | 122 | 2013 |
| Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s M Carbone, EG Flores, M Emi, TA Johnson, T Tsunoda, D Behner, ... PLoS genetics 11 (12), e1005633, 2015 | 107 | 2015 |
| Evaluation of clonal origin of malignant mesothelioma S Comertpay, S Pastorino, M Tanji, R Mezzapelle, O Strianese, ... Journal of translational medicine 12, 1-9, 2014 | 98 | 2014 |
| Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients B Vincenzi, S Galluzzo, D Santini, L Rocci, F Loupakis, P Correale, ... Annals of oncology 22 (5), 1141-1146, 2011 | 77 | 2011 |
| Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression H Yang, L Pellegrini, A Napolitano, C Giorgi, S Jube, A Preti, CJ Jennings, ... Cell death & disease 6 (6), e1786-e1786, 2015 | 76 | 2015 |
| Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies A Bononi, A Napolitano, HI Pass, H Yang, M Carbone Expert review of respiratory medicine 9 (5), 633-654, 2015 | 71 | 2015 |
| Prognostic and predictive factors in pancreatic cancer E Dell’Aquila, CAM Fulgenzi, A Minelli, F Citarella, M Stellato, F Pantano, ... Oncotarget 11 (10), 924, 2020 | 69 | 2020 |
| Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma M Carbone, D Shimizu, A Napolitano, M Tanji, HI Pass, H Yang, ... Oncotarget 7 (37), 59314, 2016 | 65 | 2016 |
| HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma L Pellegrini, J Xue, D Larson, S Pastorino, S Jube, KH Forest, ... Oncotarget 8 (14), 22649, 2017 | 61 | 2017 |
| New frontiers in the medical management of gastrointestinal stromal tumours A Mazzocca, A Napolitano, M Silletta, M Spalato Ceruso, D Santini, ... Therapeutic Advances in Medical Oncology 11, 1758835919841946, 2019 | 60 | 2019 |
| Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw B Vincenzi, A Napolitano, A Zoccoli, M Iuliani, F Pantano, N Papapietro, ... Journal of hematology & oncology 5, 1-2, 2012 | 57 | 2012 |
Michele CarboneUniversity of Hawaii在 cc.hawaii.edu 的电子邮件经过验证
